WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling

WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling

ABSTRACTWD repeat domain 62 (WDR62) is involved in embryonic brain growth through regulation of glial and neural cell populations. WDR62 is also implicated in the carcinogenesis of various cancers. The role of WDR62 in progression and chemoresistance of colorectal cancer (CRC) was investigated. Firs...

Full description

Bibliographic Details
Main Authors: Juanjuan Cai, Lingling Su, Weiwei Luo
Format: Article
Language:English
Published: Taylor & Francis Group 2022-06-01
Series:Bioengineered
Subjects:
WDR62
oxaliplatin resistance
proliferation
apoptosis
DNA damage repair
colorectal cancer
Online Access:https://www.tandfonline.com/doi/10.1080/21655979.2022.2086381

Internet

https://www.tandfonline.com/doi/10.1080/21655979.2022.2086381

Similar Items